12:30 PM - 12:45 PM (EDT), Thursday, June 8, 2023 ・ Session Room 104A
Precision NanoSystems, now part of the Danaher Life Sciences platform, is a global leader in ushering in the next wave of genomic medicines for infectious diseases, cancer, and rare diseases. Collaborating with the world’s leading drug developers to understand disease and create the therapeutics that will define the future of medicine, Precision NanoSystems offers non-viral delivery solutions, including NanoAssemblr®️ lipid nanoparticle (LNP) formulation instruments, a proprietary ionizable lipid library, off-the-shelf reagents, and biopharma services.
Company HQ State:
Company HQ Country:
Main Therapeutic Focus:
Platform for Therapeutics
Lead Product in Development:
N/A. Biotech Platform Company.
Development Phase of Primary Product:
Number Of Unlicensed Products (For Which You Are Seeking Partners):